SCHEMBL1923058

SCHEMBL1923058

CCCCC1=CC=CC[CH]1

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10354088 0.92 LIPG (0.34)
SCHEMBL10575447 0.92 LIPG (0.34)
SCHEMBL5275791 0.92 LIPG (0.34)
SCHEMBL10353853 0.92 LIPG (0.34)
SCHEMBL2153677 0.87
SCHEMBL8142478 0.79
SCHEMBL1651237 0.78
SCHEMBL4431152 0.76 BCHE (0.33)
SCHEMBL8704203 0.74
SCHEMBL4964109 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011094890-A1 PHENYLALANINE DERIVATIVES AND THEIR USE AS NON-PEPTIDE GLP-1 RECEPTOR MODULATORS ARGUSINA INC. (US) 2011-08-11 WO claimed
WO-2007144785-A2 RYANODINE RECEPTOR INHIBITORS AND METHODS RELATING THERETO UTI LIMITED PARTNERSHIP (US) 2007-12-21 WO claimed
EP-1812505-A2 STABILIZED ALIPHATIC POLYESTER COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2007-08-01 EP claimed
WO-2006055315-A2 STABILIZED ALIPHATIC POLYESTER COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 2006-05-26 WO claimed
WO-2021076693-A1 INSECTICIDAL MIXTURES OF BIFENTHRIN AND CHLORANTRANILIPROLE FMC CORPORATION (US) 2021-04-22 WO disclosed
EP-3086815-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES Zymeworks Inc. (CA) 2016-11-02 EP disclosed
WO-2015095953-A1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2015-07-02 WO disclosed
EP-2328981-A1 INKJET PRINTING SYSTEM AND INK Eastman Kodak Company (US) 2011-06-08 EP disclosed
WO-2010024904-A1 INKJET PRINTING SYSTEM AND INK EASTMAN KODAK COMPANY (US) 2010-03-04 WO disclosed
WO-2009100250-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS FIBROGEN, INC. (US) 2009-08-13 WO disclosed
EP-1973984-A1 ELECTROLUMINESCENT DEVICE INCLUDING A GALLIUM COMPLEX EASTMAN KODAK COMPANY (US) 2008-10-01 EP disclosed
WO-2007084269-A1 ELECTROLUMINESCENT DEVICE INCLUDING A GALLIUM COMPLEX EASTMAN KODAK COMPANY (US) 2007-07-26 WO disclosed
EP-1773742-A1 PROCESS FOR THE SYNTHESIS OF NAPHTHACENES IN THE PRESENCE OF AN INORGANIC BASE EASTMAN KODAK COMPANY (US) 2007-04-18 EP disclosed
WO-2006019859-A1 PROCESS FOR THE SYNTHESIS OF NAPHTHACENES IN THE PRESENCE OF AN INORGANIC BASE EASTMAN KODAK COMPANY (US) 2006-02-23 WO disclosed
US-20030114623-A1 Olefin polymer and production processes thereof MITSUI CHEMICALS, INC. (JP) 2003-06-19 US disclosed
EP-1194428-A1 HETEROARYL PROTEASE INHIBITORS AND DIAGNOSTIC IMAGING AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-04-10 EP disclosed
WO-2001004117-A1 HETEROARYL PROTEASE INHIBITORS AND DIAGNOSTIC IMAGING AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-01-18 WO disclosed